KINETICS AND ORGAN DISTRIBUTION OF [C-14] SIALIC ACID-GM3 AND [H-3] SPHINGOSINE-GM1 AFTER INTRAVENOUS-INJECTION IN RATS

被引:13
作者
DUMONTET, C
REBBAA, A
PORTOUKALIAN, J
机构
[1] Unité INSERM 218, Centre Léon Bérard
关键词
D O I
10.1016/0006-291X(92)90231-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1, administered as an intravenous bolus, were analysed in Wistar rats. [3H]-GM1 and [14C]-GM3 had serum half-lives of 1.4 hours and 1.8 hours, respectively. Three hours after injection 75% of the GM1- and 38% of the GM3-associated label were present in the liver. Smaller yet significant amounts of label were present in the central nervous system, kidneys and lung. In vitro studies showed that [14C]-GM3 and [3H]-GM1 incubated with serum were predominantly bound to the High Density Lipoprotein and the Low Density Lipoprotein fractions. These results suggest a rapid serum clearance of exogenous gangliosides by the liver in rats. © 1992.
引用
收藏
页码:1410 / 1416
页数:7
相关论文
共 17 条
[1]   EVIDENCE FOR SEVERAL CELL-POPULATIONS IN HUMAN THYROID WITH DISTINCT GLYCOSPHINGOLIPID PATTERNS [J].
BOUCHON, B ;
PORTOUKALIAN, J ;
MADEC, AM ;
ORGIAZZI, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1051 (01) :1-5
[2]   PHARMACOKINETICS OF GM1 GANGLIOSIDE FOLLOWING PARENTERAL ADMINISTRATION [J].
CORNELLI, U ;
PANUCCI, A ;
ZINGALI, G ;
KIRSCHNER, G ;
BAGGIO, C ;
GOGO, R .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (10) :708-711
[3]   RECOVERY OF MOTOR FUNCTION AFTER SPINAL-CORD INJURY - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH GM-1 GANGLIOSIDE [J].
GEISLER, FH ;
DORSEY, FC ;
COLEMAN, WP .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (26) :1829-1838
[4]  
JOURDIAN GW, 1971, J BIOL CHEM, V246, P430
[5]   HUMORAL IMMUNE-RESPONSE IN DISEASE-FREE ADVANCED MELANOMA PATIENTS AFTER VACCINATION WITH MELANOMA-ASSOCIATED GANGLIOSIDES [J].
PORTOUKALIAN, J ;
CARREL, S ;
DORE, JF ;
RUMKE, P .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (06) :893-899
[6]  
PORTOUKALIAN J, 1989, GANGLIOSIDES CANCER, P207
[7]   GM1 GANGLIOSIDE TREATMENT REDUCES VISUAL DEFICITS AFTER GRADED CRUSH OF THE RAT OPTIC-NERVE [J].
SAUTTER, J ;
SCHWARTZ, M ;
DUVDEVANI, R ;
SABEL, BA .
BRAIN RESEARCH, 1991, 565 (01) :23-33
[8]  
Scanu A M, 1973, Adv Clin Chem, V16, P111, DOI 10.1016/S0065-2423(08)60345-5
[9]   SIMPLE AND NOVEL METHOD FOR TRITIUM LABELING OF GANGLIOSIDES AND OTHER SPHINGOLIPIDS [J].
SCHWARZMANN, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 529 (01) :106-114
[10]  
SCNEIDER JS, 1992, SCIENCE, V256, P843